Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP157 is annotated as a pseudogene of the functional RNA, 7SK small nuclear (RN7SK) gene, which produces a small nuclear RNA molecular scaffold that regulates transcription elongation by controlling the activity of positive transcription elongation factor b (P-TEFb)[1][4]. The pseudogene RN7SKP157 does not encode a functional RNA product and is not implicated in any biological process, disease, or therapeutic mechanism. References to the RN7SK gene—such as transcription regulation, cell cycle control, or neurodevelopmental roles—do not apply to this pseudogene variant, and there is no evidence RN7SKP157 has functional significance distinct from the parental RN7SK gene[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 157 (RN7SKP157).